Paul Little | Chief Financial Officer |
David-Alexandre Gros | Chief Executive Officer |
Steven Perrin | President & Chief Scientific Officer |
Jeff Bornstein | Chief Medical Officer |
Matt Kaplan | Ladenburg Thalmann |
Thomas Smith | SVB Leerink |
Rami Katkhuda | LifeSci Capital |
Vernon Bernardino | H.C. Wainwright |
Greetings. Welcome to the Eledon Pharmaceuticals Reports Second Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note that this conference is being recorded.